Nano-formulation Based Drug Delivery and its Advancement for Cardiovascular Systems

Abstract

The world’s leading causes of mortality and morbidity are cardiovascular diseases (CVDs). The early
and long-term effects on patients vary widely despite recent advancements in the management of
CVDs, particularly given the difficulties in diagnosing and treating CVDs now. The use of
nanoparticles combined formulation to treat illnesses and improve health is made possible by
nanotechnology. The dispersion of therapeutic substances in the body is changed by the site-specific,
goal-oriented delivery and controlled drug release of precision medicines offered by nanoparticlebased “drug delivery systems (DDS)”. Nanoparticles made of metal, lipid, and polymer are the perfect
substances to use in cardiovascular treatments. Significantly, in recent years, researchers have found
that nanotechnologies may be useful for treating chronic illnesses, particularly cardiovascular disease
(CVD). Various approaches to using nanoparticles and their formulation as drug delivery vehicles in
CVDs have been put forth; however, disagreements over the choice of nanomaterials and their
formulation are delaying their practical application. In order to provide a safer and more effective
method for treating CVD, this review concentrates on a nano-based formulation for drug delivery and
its therapeutic function.